Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2005
03/17/2005WO2005001416A3 High throughput assay of lp-pla2 activity
03/17/2005WO2005001098A8 Wheat with altered branching enzyme activity and starch and starch containing products derived thereform
03/17/2005WO2004111271A3 Means and method for the detection of target nucleotide sequences using ligation assays with improved oligonucleotide probe pairs
03/17/2005WO2004111217A3 Variant pseudomonas polypeptides having a non-maltogenic exoamylase activity and their use in preparing food products
03/17/2005WO2004108761A3 Canine ghrh gene, polypeptides and methods of use
03/17/2005WO2004106488A3 Gene expression suppression agents
03/17/2005WO2004101802A3 Spheroplast fusion
03/17/2005WO2004101801A3 Improved method for producing non-pathogenic helper virus-free preparations of herpes virus amplicon vectors, the helper virus & the cells used in this method, the corresponding generic tools, as well as the applications of these non-pathogenic amplicons vectors
03/17/2005WO2004092194A3 Chimeric polypeptides and their use
03/17/2005WO2004090142A8 Plants having modified growth characteristics and method for making the same
03/17/2005WO2004090141A8 Method to increase stress tolerance in plants
03/17/2005WO2004090094A3 L-carnitin dehydrogenases, their derivatives and method for producing substituted (s) alkanols
03/17/2005WO2004089073A3 Inducible breast cancer model
03/17/2005WO2004087867A3 Methods for the identification of inhibitors of serine acetyltransferase activity in plants
03/17/2005WO2004087749A3 Nontypeable haemophilus influenzae virulence factors
03/17/2005WO2004085607A3 Texturizing lactic bacteria
03/17/2005WO2004084874A3 Mtp inhibitors for inhibiting inflammation
03/17/2005WO2004084797A3 Type 2 diabetes mellitus-associated gene and utilization of the same
03/17/2005WO2004081166A3 Nucleotide sequences of coryneform bacteria coding for proteins involved in l-serine metabolism and method for producing l-serine
03/17/2005WO2004080287A3 Method of killing cancer cells
03/17/2005WO2004076675A3 Glutamate transport modulatory compounds and methods
03/17/2005WO2004076619A3 New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
03/17/2005WO2004074461A3 Production of modified glycoproteins having multiple antennary structures
03/17/2005WO2004072235B1 Cotton event mon 88913 and compositions and methods for detection thereof
03/17/2005WO2004072098A3 Immunocompromised rodents as dual color tumor models
03/17/2005WO2004067727A3 Mixing and matching tc proteins for pest control
03/17/2005WO2004061081A3 Sirna compounds and methods for the downregulation of gene expression
03/17/2005WO2004058822A3 Generation of immunoglobulin molecules with predetermined specificity
03/17/2005WO2004058815A3 Centrosome-associated protein and applications thereof
03/17/2005WO2004048403A3 Hepatisis c virus nonstructural protein 4a (ns4a) is an enhancer element
03/17/2005WO2004044177A3 Expression profiling based on histocultures
03/17/2005WO2004041851A3 Vaccine
03/17/2005WO2004024079A8 Methods and compositions for production of flavonoid and isoflavonoid nutraceuticals
03/17/2005WO2004022729A8 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
03/17/2005WO2004018703A3 Recombinant chalcomycin polyketide synthase and modifying genes
03/17/2005WO2004016761A3 Gene therapy for critical limb ischemia with wild type or mutant enos
03/17/2005WO2004015123A8 Tissue specific expression of exogenous proteins in transgenic chickens
03/17/2005WO2004010767A3 Application of aspen mads-box genes to alter reproduction and development in trees
03/17/2005WO2004009796A3 Single promoter system for making sirna expression cassettes and expression libraries using a polymerase primer hairpin linker
03/17/2005WO2003101484A9 Compositions and methods for transepithelial molecular transport
03/17/2005WO2003097811A3 Cellular gene targets for controlling cell growth
03/17/2005WO2003092360A3 Novel glyphosate-n-acetyltransferase (gat) genes
03/17/2005WO2003089899A3 Probes for detecting tumor cells
03/17/2005WO2003078575A3 Molecular switches and methods for making and using the same
03/17/2005WO2003061564A8 Gene expression profiles in liver disease
03/17/2005WO2003018814A8 Enzymes involved in the triacylglycerol biosynthesis in the cytosol of eukaryotes
03/17/2005WO2003016489A8 Porcine leptin protein, antisense and antibody
03/17/2005WO2003011898A3 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
03/17/2005WO2002100530A8 Method for controlling fermentation
03/17/2005WO2002079227A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/17/2005WO2002074156A8 Compositions and methods for the therapy and diagnosis of colon cancer
03/17/2005WO2002072804A9 Novel genes for conditional cell ablation
03/17/2005US20050060779 Lectin-derived progenitor cell preservation factors and methods of use
03/17/2005US20050060777 High frequency plant transformation and/or regeneration
03/17/2005US20050060776 Expression of biologically active polypeptides in duckweed
03/17/2005US20050060775 Using expression vector comprising nucleotide sequence coding antihemophilic factor to generate transgenic plant; bioreactors and heterologous gene expression
03/17/2005US20050060774 Arabidopsis thaliana derived frigida gene conferring late flowering
03/17/2005US20050060773 Expression vector comprising nucleotide sequences coding gene associated with plant dwarfing (RHT) for use as tool in establishing seedling development in plants
03/17/2005US20050060772 Controlling abscission in a transformed plant comprising overexpression of ethylene insensitivity (EIN) gene; tissue engineering and plant storage stability; flower senescence and fruit ripening
03/17/2005US20050060771 siRNA encoding constructs and methods for using the same
03/17/2005US20050060770 Antifungal proteins
03/17/2005US20050060769 Preparing fertile transgenic cell of maize via site directed genetic rearrangement; plant tissue engineering and pharmaceuticals and/or nutraceuticals
03/17/2005US20050060768 genetic constructs comprising a first lethal gene and a second gene adapted for expression in a plant cell, wherein the second gene confer novel traits to the plants
03/17/2005US20050060767 DNA shuffling to produce herbicide selective crops
03/17/2005US20050060766 Cloning non-human mammal through nuclear transfer/transplantation; tissue engineering and treatment of cancer, psoriasis, asthma and inflammation
03/17/2005US20050060764 Mouse model for bone metabolism
03/17/2005US20050060763 Transgenic rodent model for use as tool in analysing the importance of light (L) chain expression for antibody development; immunotherapeutics
03/17/2005US20050060762 Plasmid construct comprising hybrid alpha -lactalbumin promoter for use as gene transfer and expression tool in genetic engineering; gene therapy and tissue engineering
03/17/2005US20050059816 Novel human protease inhibitor proteins and polynucleotides encoding the same
03/17/2005US20050059815 Processes for the synthesis of 2'-O-substituted pyrimidines and oligomeric compounds therefrom
03/17/2005US20050059807 Transcriptional modulator for use in the treatment and prevention of cell proliferative, muscular, blood, gastrointestinal and cardiovascular disorders
03/17/2005US20050059803 Oligonucleotide probe for use in detection of phosphatidyl inositol 3 kinase expression; fungicides; antitumor agents
03/17/2005US20050059801 Transmembrane receptor/chemokine receptor for use in identifying modulators for treatment of glomerulonephritis, asthma, inflammatory bowel, transplant rejection and inflammation
03/17/2005US20050059633 Novel glucans and novel glucansucrases derived from lactic acid bacteria
03/17/2005US20050059629 Antisense modulation of connective tissue growth factor expression
03/17/2005US20050059628 Modulation of beta-catenin/TCF-activated transcription
03/17/2005US20050059627 Administering antisense oligonucleotides against the mRNA of corticotropin releasing factor subtype-2 (CRF2) receptor; treating anxiety, obsessive-compulsive disorder, panic disorders, post-traumatic stress, phobias and depression
03/17/2005US20050059626 Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences
03/17/2005US20050059625 Immunostimulatory nucleic acid molecules
03/17/2005US20050059623 linking chaperone protein promoters to genetically engineered genes, then heating
03/17/2005US20050059621 preventing apoptosis in neurons that occurs in the presence of beta -amyloid protein, during or after hypoxia or when the neuron exhibits an elevated intracellular calcium concentrations, comprising administering tyrosine kinase inhibitors; treating neurodegenerative diseases
03/17/2005US20050059619 Immunostimulatory nucleic acids
03/17/2005US20050059618 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
03/17/2005US20050059617 Novel anitsense oligonucleotide derivatives against to hepatitis c virus
03/17/2005US20050059586 For increasing expression of human presenilin; for treatment of neurodegenerative diseases, Alzheimer's disease; drug screening
03/17/2005US20050059577 Glycosylphosphatidylinositol containing polypeptides
03/17/2005US20050059169 Solid support comprising reflection-suppressing function and capable of producing high signal intensity from a fluorescent molecule; improved quantification performance
03/17/2005US20050059154 Method to modify cell number, architecture and yield of plants by overexpressing the e2f transcription factor
03/17/2005US20050059144 MHC class II antigen-presenting systems and methods for activating CD4+ T cells
03/17/2005US20050059137 Bio-support and preparing method of the same
03/17/2005US20050059135 Methods and compositions for identifying receptor effectors
03/17/2005US20050059132 Variant blood coagulation factor for use as tool in treatment of thrombosis
03/17/2005US20050059131 Detergent compositions containing amylase variants
03/17/2005US20050059130 Lipolytic enzyme variants
03/17/2005US20050059127 Method for recovering proteins from the interstitial fluid of plant tissues
03/17/2005US20050059126 Engineered enzymes comprised of protein scaffold and specificity determining regions; fusion proteins, nucleic acid molecules, vectors, host cells
03/17/2005US20050059124 Using trangenic gramnegative bacteria exhibiting an overexpression of succinyl-CoA synthetase (SUC) as bioreactor for fermentation of threonine for use in medicine, cosmetics and animal feeds
03/17/2005US20050059123 Using allelic variation to differentiate animal products on basis of breed origin
03/17/2005US20050059121 Colony stimualting factor for use in animal vaccination and as nonspecific immunity stimulant; veterinary medicine
03/17/2005US20050059116 Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents
1 ... 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 ... 4023